Health and Fitness Health and Fitness
Thu, January 15, 2009
Wed, January 14, 2009

SurModics to Webcast Fiscal 2009 First Quarter Earnings Conference Call January 28


Published on 2009-01-14 13:12:11, Last Modified on 2009-01-14 13:12:46 - Market Wire
  Print publication without navigation


EDEN PRAIRIE, Minn.--([ BUSINESS WIRE ])--SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it will host a live webcast of its fiscal 2009 first quarter conference call on Wednesday, January 28, at 4:00 p.m. CT. The Company will issue an earnings news release after the market closes that afternoon.

Bruce Barclay, president and chief executive officer, and Phil Ankeny, senior vice president and chief financial officer, will recap the first quarter financial results and accomplishments. To access the webcast, go to the investor relations portion of the Company's website at [ www.surmodics.com ] the day of the conference call and click on the webcast icon.

An audio replay will be available beginning at 7:00 p.m. CT on Wednesday, January 28, until 7:00 p.m. CT on Wednesday, February 4 and can be accessed by dialing 800-405-2236 and entering conference call ID passcode 11124580. In addition, the conference call audio will be archived on the Company's website following the call.

About SurModics, Inc.

SurModics, Inc. is a leading provider of drug delivery and surface modification technologies to the healthcare industry. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to develop and commercialize innovative products that result in improved patient outcomes. Core offerings include: drug delivery technologies (coatings, microparticles, nanoparticles, and implants); surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and specialized surfaces for cell culture and microarrays. SurModics is headquartered in Eden Prairie, Minnesota and its Brookwood Pharmaceuticals subsidiary is located in Birmingham, Alabama. For more information about the Company, visit [ www.surmodics.com ]. The content of SurModics' website is not part of this release or part of any filings the Company makes with the SEC.

Contributing Sources